Cross-contamination of infusion solutions was identified in numerous batches of B. Braun products, meaning the presence of incorrect active substances or their residues in bottles intended for intravenous administration, breaching quality and safety requirements. Potential effects: severe adverse reactions, poisoning, lack of efficacy or complications of intravenous therapy.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use the listed batches of B. Braun infusion solutions. Check batch numbers and GTINs and return products covered by the decision to a (hospital) pharmacy. If a batch has been administered, moni...
The Chief Pharmaceutical Inspector withdrew the specified batches of B. Braun infusion solutions from the national market and granted the decision immediate enforceability, following notification of c...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related